Skip to main content

Table 2 Admission variables and outcome in 553 patients treated with atovaquone-proguanil for imported uncomplicated malaria

From: Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases

Temperature at diagnosis N (%)

≤37.7C°

175 (31.6)

37.8-39C°

208 (37.6)

39.1-40C°

104 (18.8)

>40C°

19 (3.4)

Symptoms at diagnosis

 

Headache

256 (46.3)

Nausea/vomiting

156 (28.2)

Diarrhoea

102 (18.5)

Myalgia

81 (14.7)

Abdominal pain

32 (5.8)

Arthralgia

20 (3.6)

Compliance to follow-up

 

Day 3

469 (84.1)

Day 7

364 (65.8)

Day 30

265 (47.9)

Hospitalization

 

Hospitalized at diagnosis

191 (34.5)

Still hospitalized at day 3

124 (22.4)

Still hospitalized at day 7

15 (2.7)

Still hospitalized at day 30

2 (0.3)

Fever clearance (apyrexia)

 

Day 3

403/425* (94.8)

Day 7

323/323* (100)

Day 30

227/227* (100)

Parasitological clearance (negative parasitaemia)

 

Day 3

292/425* (68.7)

Day 7

331/331* (100)

Day 30

215/217* (99.1)

  1. *: number of patients with available data.